Lupin 2024

Issue 01-02-2012

Cosby looks to be good fit at CVS/pharmacy

Mark Cosby made his first public appearance as CVS/pharmacy president last month during CVS Caremark’s 2011 conference for investors and financial analysts. For anyone who may have had doubts about the wisdom of recruiting a department store executive to a run a drug chain, his performance was reassuring. First and foremost, Cosby, who prior to

Outlook for biopharmaceutical sector is bright

Some recent media coverage of the biopharmaceutical industry has painted something of a doomsday picture — patent cliffs, stagnant pipelines, the end of the blockbuster era, etc. In reality, the prospects of the biopharmaceutical sector — for patients in search of new medicines, for policy makers seeking value in the health care system and for

PP_1170x120_10-25-21